The United States administration, through the US Agency for International Development (USAID), sent a cargo of emergency medical stocks to Pakistan, in the countries joint endeavor to combat the plague of COVID.
The donation also included $3.5 million in extra funding for local processes of health-related quotas to support the overall COVID-19 response.
Earlier in June, USAID delivered baggage of protective tools and fingertip oximeters to be delivered to Pakistani healthcare faculties, throughout the nation.
USAID also provided 200 ventilators and educated more than 600 health workers in 64 Pakistani hospitals.
The merchandises, managed by the US Agency for International Development, are part of a programme to “help save lives” by meeting pressing health necessities across South Asia, the State Department’s announcer Ned Price told at a news briefing in Washington.
In addition, USAID has enhanced and broadened laboratory testing, ailment monitoring, case quest in all areas, infection prevention and control, and patient care.
The USAID press release stated that the United States and Pakistan had worked jointly and very closely to answer back to the Covid-19 pandemic, and “this donation is being made at Islamabad’s request”. The US had allocated $40 million to Pakistan for Covid-19 response aid.
Today, the United States is gratified to support the Government of Pakistan in protecting the country’s frontline healthcare workers in the battle against COVID-19. During this unusual time, the United States will proceed to work together with Pakistan to provide critically needed medical supplies, said USAID Mission Director Julie Koenen.
Unicef estimates that an additional $2 billion is needed to help the poorest 92 countries to pay for requisites such as fridges, health worker training, expenditures for vaccinators, and energy for the refrigerated delivery vehicles. The agency has urged donors to make $510m of this available immediately to address serious shortages. The UN report also urged wealthier governments to share surplus doses.